Suzanne Bruce
Dermatology · Houston, TXNPI 1588661979
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (34.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 87.6% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $38,514 and has fallen 98.5% since, to $595 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 258 payments — averaging $203.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$46K
- Galderma Laboratories, L.p.$2K
- Merz North America, Inc.$1K
- Revance Therapeutics, Inc.$987
- Almirall LLC$925
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$354
- plus $820 from 13 others
Across 235 payments — averaging $9349.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$696K
- Novartis$695K
- Biofrontera Inc.$346K
- Amgen$213K
- Eli Lilly$110K
- Pfizer$44K
- plus $92K from 8 others
What the payments were for
- Consulting fees$15,60030%
- Speaking & faculty fees$17,95034%
- Travel & lodging$10,45220%
- Food & beverage$8,48016%
- Education$1310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 124 | $46,106 |
| Galderma Laboratories, L.p. | 58 | $1,992 |
| Merz North America, Inc. | 17 | $1,430 |
| Revance Therapeutics, Inc. | 18 | $987 |
| Almirall LLC | 2 | $925 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $354 |
| Novartis | 8 | $227 |
| Lilly USA, LLC | 5 | $140 |
| Johnson & Johnson | 4 | $119 |
| Sun Pharmaceutical Industries Inc. | 3 | $76 |
| Arcutis Biotherapeutics, Inc. | 3 | $68 |
| Dermira, Inc. | 2 | $60 |
| Pfizer | 2 | $23 |
| UCB, Inc. | 1 | $23 |
| VYNE Pharmaceuticals Inc. | 1 | $21 |
| Journey Medical Corporation | 1 | $17 |
| Encore Dermatology Inc. | 1 | $15 |
| Aclaris Therapeutics, Inc. | 1 | $15 |
| Botanix SB Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,613 in reported general payments places this provider in the 90th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 20 | $247 |
| Ketoconazole | 16 | $226 |
| Ketorolac Tromethamine | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Houston
- Alpesh DesaiHouston$1.6M
- Geeta PatelHouston$575K
- Michael MigdenHouston$310K
- Catherine PapasakelariouHouston$289K
- Stephen MahoneyHouston$137K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.